Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Carmichael

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Obstetrics and Gynecology|July 1, 1991
A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapyC Kirkham, P M Hahn, D A Van Vugt, et al.
Obstetrics and Gynecology|March 1, 1988
Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomyW E Shelley, A A Starreveld, J A Carmichael, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2004
Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptorV A Streltsov, J N Varghese, J A Carmichael, et al.
Gynecologic Oncology|December 1, 1991
Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical stagingM Monga, J A Carmichael, W E Shelley, et al.
Gynecologic Oncology|July 1, 1987
A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic testJ A Carmichael, W E Shelley, L B Brown, et al.
Cancer Treatment Reports|March 1, 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatinJ L Pater, J A Carmichael, G V Krepart, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Obstetrics and Gynecology|July 1, 1991
A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapyC Kirkham, P M Hahn, D A Van Vugt, et al.
Obstetrics and Gynecology|March 1, 1988
Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomyW E Shelley, A A Starreveld, J A Carmichael, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2004
Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptorV A Streltsov, J N Varghese, J A Carmichael, et al.
Gynecologic Oncology|December 1, 1991
Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical stagingM Monga, J A Carmichael, W E Shelley, et al.
Gynecologic Oncology|July 1, 1987
A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic testJ A Carmichael, W E Shelley, L B Brown, et al.
Cancer Treatment Reports|March 1, 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatinJ L Pater, J A Carmichael, G V Krepart, et al.
Pageof 3